jkk002

Julie K. Karp, MD

Contact Dr. Karp

111 South 11th Street
Room 8220 Gibbon
Philadelphia, PA 19107

(215) 503-4838
(215) 923-9387 fax

Most Recent Peer-reviewed Publications

  1. Correlating Transfusion Medicine In-Service Examination Scores with Outcomes of the American Board of Pathology Transfusion Medicine Subspecialty Certifying Examination
  2. The role of therapeutic plasma exchange in clinically amyopathic dermatomyositis with MDA-5 antibody: A case report and review of the literature
  3. Point-of-care versus central testing of hemoglobin during large volume blood transfusion
  4. Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion
  5. Revisiting the role of therapeutic plasma exchange in the management of catastrophic antiphospholipid syndrome
  6. The BEST criteria improve sensitivity for detecting positive cultures in residual blood components cultured in suspected septic transfusion reactions
  7. Regulatory requirements need to specifically address prehospital transfusion programs
  8. Transfusion-transmitted babesiosis
  9. Intravenous vitamin K as a cause of bright yellow plasma discoloration
  10. Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model
  11. The definition of severe systemic lupus erythematosus needs clarification in the next ASFA guidelines
  12. Pathology and professionalism in the age of social media
  13. Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee
  14. Safety of the use of group A plasma in trauma: the STAT study
  15. I am Cait, and I am a transgender blood donor
  16. Statistical literacy among academic pathologists: A survey study to gauge knowledge of frequently used statistical tests among trainees and faculty
  17. Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion
  18. Does therapeutic plasma exchange have a role in the treatment of prosthetic hip–associated cobalt toxicity? A case report and literature review
  19. Myositis is a category IV indication for plasmapheresis
  20. Transfusion-related acute lung injury in an era of TRALI risk mitigation